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Abstract: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver
disease in children, with prevalence rising alongside childhood obesity rates. This study aimed to
characterise the habitual diet and activity behaviours of children with NAFLD compared to obese
children without liver disease in the United Kingdom (UK). Twenty-four biopsy-proven paediatric
NAFLD cases and eight obese controls without biochemical or radiological evidence of NAFLD
completed a 24-h dietary recall, a Physical Activity Questionnaire (PAQ), a Dutch Eating Behavior
Questionnaire (DEBQ) and a 7-day food and activity diary (FAD), in conjunction with wearing
a pedometer. Groups were well matched for age and gender. Obese children had higher BMI
z-scores (p = 0.006) and BMI centiles (p = 0.002) than participants with NAFLD. After adjusting
for multiple hypotheses testing and controlling for differences in BMI, no differences in macro- or
micronutrient intake were observed as assessed using either 24-h recall or 7-day FAD (p > 0.001).
Under-reporting was prevalent (NAFLD 75%, Obese Control 87%: p = 0.15). Restrained eating
behaviours were significantly higher in the NAFLD group (p = 0.005), who also recorded more steps
per day than the obese controls (p = 0.01). In conclusion, this is the first study to assess dietary
and activity patterns in a UK paediatric NAFLD population. Only a minority of cases and controls
were meeting current dietary and physical activity recommendations. Our findings do not support
development of specific dietary/ physical activity guidelines for children with NAFLD; promoting
adherence with current general paediatric recommendations for health should remain the focus of
clinical management.
Keywords: non-alcoholic fatty liver disease; nutrition; obesity; physical activity; eating behaviour;
adolescence; children
1. Introduction
Non-alcoholic fatty liver disease (NAFLD) is a condition characterised by fat accumulation in
the liver with or without inflammation and fibrosis (non-alcoholic steatohepatitis; NASH), which has
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the potential to progress to end stage liver disease and/or hepatocellular carcinoma [1]. NAFLD
is currently the most common form of chronic liver disease in children and adolescents in Western
countries, with prevalence rising alongside rates of childhood obesity [2]. The gold standard for
diagnosis of NASH is liver biopsy, which, due to its invasive nature and associated risks, has
made establishing accurate population prevalence data for paediatric NAFLD difficult [3]. However,
in an autopsy study of 742 children who died from unnatural causes in the United States (US),
Schwimmer et al., found a NAFLD prevalence of 9.6%, which increased to 38% in obese children [4].
Due to a lack of evidence to support pharmacological treatment options for NAFLD, diet and
physical activity play a key role in NAFLD management [5,6]. First-line treatment is currently the
promotion of gradual weight loss through reduced energy intake and increased physical activity,
with the aim of improving liver function tests (LFTs), insulin resistance (IR), fasting glucose and
lipid profiles [5,6]. However, the role of specific dietary nutrients and the influence of physical
activity levels on NAFLD pathogenesis remain uncertain. Nutrients previously investigated in
NAFLD pathogenesis include fructose, saturated fatty acids (SFA), mono-unsaturated fatty acids
(MUFA), polyunsaturated fatty acids (PUFA) and vitamin D. Quality of dietary fat seems likely to
play a role in NAFLD development with a significant body of evidence suggesting that consumption
of an isocaloric diet rich in SFA may contribute to hepatic fat accumulation; whereas a diet rich in
PUFA, in particular omega-3 fatty acids, may impede steatosis development [7].
More recently, there has been increasing research into the role of fructose in NAFLD
pathogenesis [8]. Although high fructose intakes have been shown to alter hepatic insulin sensitivity
and increase lipogenesis, whether or not this contributes to NAFLD pathogenesis independent of
excess energy consumption remains uncertain [8]. Equally, vitamin D has been implicated in NAFLD
development [9] with observational studies demonstrating that low vitamin D status is associated
with NAFLD independently of body mass index in Australian [10], and Italian [11] paediatric cohorts.
Additionally, physical activity is believed to contribute to NAFLD development with studies in both
adults [12–14] and children [15,16] identifying high rates of physical inactivity amongst individuals
with NAFLD.
In this context, the aims of this study were to characterise and compare the dietary and physical
activity patterns of a group of UK children with NAFLD to obese children without evidence of liver
disease; and furthermore to relate nutrient intakes to UK recommended dietary reference values and
exam if excess intakes or deficiencies of nutrients previously implicated in NAFLD pathogenesis are
evident in a UK paediatric cohort.
2. Materials and Methods
2.1. Participants
All participants were recruited from paediatric clinics at King’s College Hospital, London.
Children with NAFLD were recruited from the Paediatric Liver Centre, whereas obese controls were
recruited from a regional surgical weight loss clinic following a diagnosis of simple non-syndromic
obesity and were invited into the study prior to any lifestyle intervention. All subjects were
less than 18 years of age and did not consume alcohol. Cases required a diagnosis of NAFLD
(initially suspected based on ultrasound or elevated liver enzymes) confirmed by liver biopsy within
3–6 months. Patients underwent a full work up for chronic liver disease including screening for
Hepatitis B and C, Wilson disease (including liver copper quantification), autoimmune liver disease
and alpha 1 antitrypsin deficiency. Cases were excluded in the presence of other chronic liver
disease, or if they had previously received treatment for NAFLD. Controls were excluded if they
had a clinical suspicion of NAFLD, based on abnormality of liver function tests or liver ultrasound.
Written consent from parents/carers and assent from participants was obtained prior to entering the
study. Ethical approval was granted by the National Health Service Ethics Service (10/H0808/122)
and the University of Surrey Ethics Committee (EC/2010/115/FHMS).
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2.2. Demographic and Anthropometric Data
Participant ethnicity was classified according to the Health and Social Care Information Center,
Ethnic Category Code [17]. Weight (to the nearest 0.1 kg) and height without shoes (to the nearest
0.1 cm) were measured using digital scales and a commercial stadiometer (Marsden Weighing Group,
Rotherham, UK). Body Mass Index (BMI) was calculated as weight (kg)/height (m2). BMI centile
was read from the “Body mass index (BMI) 2–20 years” chart from the Royal College of Paediatrics
and Child Health (RCPCH), using BMI, gender and age [18]. BMI z-score was obtained using
The Children’s Hospital of Philadelphia, “Pediatric Z-Score Calculator” [19]. Weight classification
was determined using BMI ranges published by the National Health Service, National Obesity
Observatory [20]. Waist circumference (WC) was measured at the midway point between the top
of the iliac crest and the bottom of the rib cage, using a commercial tape measure and reading to the
nearest 0.5 cm [21]. If identification of these points was not possible in very overweight participants,
the tape measure was placed around the abdomen at the level of the umbilicus [21]. Mid-upper arm
circumference (MUAC) was recorded to the nearest 0.5 cm with a commercial tape measure and tricep
skinfold thickness was measured to the nearest 0.1 mm using calipers (Holtain Tanner/Whitehouse
Skinfold Caliper, Holtain Limited, Pembrokeshire, UK) [22].
2.3. Dietary Assessment
Dietary intakes were assessed using 24-h dietary recall and a 7-day participant-completed food
diary. The 24-h dietary recall was completed at the time of consent by a research dietitian using
the multiple-pass method [23]. To complete the 7-day food diary, participants were requested to
document all meals, snacks and beverages consumed over 7 consecutive days; stating brand names
where applicable and using household measures or food packaging information to estimate portion
sizes. Participants were asked to photograph all food and beverages consumed on two of their
recording days and to complete the diary during school term time. During the first 2–3 days of their
recording period, participants were offered support via telephone call or home visit. After completing
the food diary, participants were contacted by researchers to ascertain missing information.
Nutritional analyses were done using DietPlan6 (Forestfield Software Limited, West Sussex, UK).
Dietary intakes are presented as a percentage of age- and gender-specific UK dietary reference values
(DRVs) where possible [24]. Mean absolute intakes are given for nutrients that do not have DRVs.
Under-reporting of dietary intake was determined using cut-offs described by Goldberg et al. [25]. If
reported energy intake (EI) in the 7-day food diary was <1.14ˆ Basal Metabolic rate (BMR) or 24-h
recall data indicated an EI <0.92ˆ BMR, the participant was assumed to be under-reporting. BMR
was calculated using equations determined by Schofield et al. [26].
The 33-question Dutch Eating Behaviour Questionnaire (DEBQ) was completed by each
participant at the conclusion of the 7-day recording period to assess eating styles and behaviours
that may influence the likelihood of being overweight [27]. Participants responded to questions
on a 5-point Likert scale. Responses are classified as expressing emotional, external or restrained
eating behaviours. External eating behaviours include eating in response to food stimuli regardless of
internal state of hunger or satiety. Emotional eating is consumption in response to arousal states such
as anger, fear or anxiety; whereas restrained eating involves restricting food intake independently of
emotional or external cues [27].
Following dietary assessment, participants received tailored advice to improve the nutritional
quality of their diet, with a focus on healthy eating for weight management, via telephone call or
home visit.
2.4. Physical Activity Assessment
Physical activity was assessed via a participant-completed 7-day physical activity diary.
Participants were instructed to document all activity in 10 minute intervals on 7 consecutive days.
9723
Nutrients 2015, 7, 9721–9733
Participants were provided with a pedometer (OMRON Step counter Walking style III, OMRON
Healthcare Europe B.V., Hoofddorp, The Netherlands) and were instructed to document their daily
step count on each of the 7 days. Participants received support with diary completion during the first
2–3 days of their recording period, through telephone calls and/or a home visit.
Upon return of the diaries, researchers assigned a metabolic equivalent of task (MET) to each
activity using values described by Ainsworth et al. [28]. Activity was categorised as: sleep (0.9 METs),
sedentary (1.0–1.5 METs), light (1.6–2.9 METs), moderate (3.0–5.9 METs) or vigorous (ě6 METs) [28].
Periods of time that had not being recorded were classified as unaccounted time. Absolute minutes
spent in each category were calculated for each participant, along with 7-day, weekday and weekend
averages for each group. Data are presented as a percentage of 24-h.
In addition, participants ě15 years of age completed the Youth Physical Activity Questionnaire
(YPAQ) and children ď14 years completed the Children’s Physical Activity Questionnaire (C-PAQ)
with the aid of a parent or guardian [29,30]. These questionnaires assessed the number of absolute
minutes spent undertaking sedentary, light, moderate or vigorous exercise per week; with data
presented as a percentage of total time recorded.
2.5. Statistical Analysis
Statistical analysis was completed using SPSS v22 (IBM SPSS Statistics, Hampshire, UK).
Data are expressed as median ˘ interquartile range (IQR) unless otherwise specified. Due to the
small sample size, non-parametric tests were used to reduce the likelihood of a type 1 error. To
identify differences between groups, data were analysed using the Mann-Whitney test. Analysis
of Covariance (ANCOVA) was used to correct for differences in BMI z-score between groups.
Categorical baseline data and differences in the number of under-reporters were analysed using the
Fisher Exact test. The Freidman test was used to assess for differences in types of eating behaviours
within each group; with the Wilcoxon paired rank test used to assess differences between eating styles
if p < 0.05. The Wilcoxon paired rank test was used to assess differences in physical activity levels and
pedometer data between weekdays and weekends within each group. The Bonferroni Correction
was used to determine a p-value to assess for group differences in macro- and micronutrient intakes.
Otherwise, a p-value of <0.05 was considered statistically significant.
3. Results
3.1. Study Population
During the study period, 72 children attending King’s College Hospital paediatric clinics with
NAFLD or simple obesity were approached to take part in the study. Of the 51 participants who
consented to participate, 24 patients with NAFLD (63%) and 8 obese controls (61%), who had no
evidence of fatty liver disease on abdominal ultrasound or liver function tests, completed the study
protocol (Figure 1). Anthropometric and demographic data of the participants who completed the
study protocol are outlined in Table 1. Participants ranged from 8 to 18 years of age. Groups
were evenly matched for most characteristics. Although the BMI z-score (p < 0.01) and BMI centile
(p < 0.01) were significantly higher in the obese control group; there were no significant differences
in the distribution of weight classification between groups (p = 0.99). Self- (or Guardian) reported
ethnicity [17] varied between groups with predominantly White British participants in the NAFLD
group (79%) and Black British children in the obese group (75%).
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Figure 1. Participant flow diagram for the case‐control study. 
Table 1. Population characteristics of NAFLD and obese control groups. 
Characteristics 1  Unit  NAFLD (n = 24) Control (n = 8)  p‐Value 2
Gender  n (%)  Females 12 (50)  Females 5 (62.5)  0.69 a 
Males 12 (50)  Males 3 (37.5) 
Ethnicity  n (%) 
Black British 0 (0)  Black British 6 (75) 
<0.001 a White 19 (79)  White 2 (25) 
Asian 5 (21)  Asian 0 (0) 
Weight classification  n (%) 
Healthy Weight Range 1 (4) Health Weight Range 0 (0) 
0.99 a Overweight 4 (17)  Overweight 1 (12.5) 
Obese6 (25)  Obese 2 (25) 
Extremely Obese 13 (54)  Extremely Obese 5 (62.5) 
Age  years  13.5 (12.0,15.0)  12.0 (9.5,16.5)  0.59 
Weight  kg  83.3 (71.2,105.0)  86.4 (77.2,136.5)  0.27 
Height  cm  163.0 (159.1,170.9)  161.6 (148.1,173.7)  0.61 
BMI  kg/m2  31.0 (27.1,36.5)  38.4 (30.8,44.1)  0.05 
BMI centile  ‐  99.3 (98.0,99.6)  99.6 (98.0,99.6)  0.002
BMI z‐score  ‐  2.1 (1.9,2.3)  2.6 (2.4,2.7)  0.006
Waist circumference  cm  101.0 (97.5,112.0)  113.0 (95.0,133.0)  0.31 
Triceps skinfold  mm  30.5 (23.6,34.5)  37.0 (32.2,43.6)  0.08 
MUAC  cm  32.0 (30.0,36.4)  34.5 (29.1,34.5)  0.62 
1 Characteristic is expressed as median (1st quartile, 3rd quartile) unless otherwise specified. Italics are 
here for the ease of visualisation indicating 1st and 3rd quartile ranges; 2 p‐value derived from 
Mann‐Whitney Test unless otherwise specified;  a Fisher’s exact  test. p < 0.05  in bold  is considered 
statistically significant. BMI: Body Mass Index; MUAC: Mid Upper Arm Circumference. 
3.2. Dietary Intakes 
Overall, participants  in both groups did not meet  the DRV  for most nutrients and had high 
intakes of protein, sodium, vitamin B12 and vitamin C; consuming well above the DRV (Table 2). 
Assessment of the 7‐day diaries indicated that both the control and obese groups reported intakes of 
energy, fat, MUFA, PUFA, potassium, calcium, iron, zinc and folate below their DRVs. Participants 
in the NAFLD group consistently recorded median intakes of PUFA lower than the controls, while 
protein, SFA,  iron,  copper  and zinc  intakes appeared higher  in NAFLD  compared  to  controls as 
compared by 24‐h recall. However, after correction for multiple hypotheses testing, there were no 
significant differences in macro‐ and micronutrient intakes between the NAFLD group and the obese 
(Table 2). There continued to be no difference between groups after correcting for BMI z‐score (p > 
. rti i t fl i -
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Characteristics 1 Unit NAFLD (n = 24) Control (n = 8) p-Value 2
Gender n (%)
Females 12 (50) (62.5)
0.69 aMales 12 (50) l s ( 7.5)
Ethnicity n (%)
Black British 0 (0) l c ritis 6 (75)
<0. 01 aWhite 19 (79) ( 5)
Asian 5 (21) sian 0 (0)
Weight classification n (%)
Healthy Weight Range 1 (4) Healt t ange 0 (0)
0.99 a
Overweight 4 (17) r i t (12.5)
Obese6 (25) Obese 2 (25)
Extremely Obese 13 (54) Extremely Obese 5 (62.5)
Age years 13.5 (12.0,15.0) 12.0 (9.5,16.5) 0.59
Weight kg 83.3 (71.2,105.0) 86.4 (77.2,136.5) 0.27
Height cm 163.0 (159.1,170.9) 161.6 (148.1,173.7) 0.61
BMI kg/m2 31.0 (27.1,36.5) 38.4 (30.8,44.1) 0.05
BMI centile - 99.3 (98.0,99.6) 99.6 (98.0,99.6) 0.002
BMI z-score - 2.1 (1.9,2.3) 2.6 (2.4,2.7) 0.006
Waist circumf rence cm 10 .0 (97.5,112.0) 113.0 (95.0,133.0) 0.31
Triceps skinfold m 3 .5 (23.6,34.5) 37. (32.2,43.6) 0. 8
MUAC cm 32.0 (30.0,36.4) 34.5 (29.1,34.5) 0.62
1 Characteristic is expressed as median (1st quartile, 3rd quartile) unless otherwise specified; 2 p-value derived
from Mann-Whitney Test unless otherwise specified; a Fisher’s exact test. p < 0.05 in bold is considered
statistically significant. BMI: Body Mass Index; MUAC: Mid Upper Arm Circumference.
3.2. Dietary Intakes
Overall, participants in both groups did not meet the DRV for most nutrients and had high
intakes of protein, sodium, vitamin B12 and vitamin C; consuming well above the DRV (Table 2).
Assessment of the 7-day diaries indicated that both the control and obese groups reported intakes of
energy, fat, MUFA, PUFA, potassium, calcium, iron, zinc and folate below their DRVs. Participants
in the NAFLD group consistently recorded median intakes of PUFA lower than the controls, while
protein, SFA, iron, copper and zinc intakes appeared higher in NAFLD compared to controls as
compared by 24-h recall. However, after correction for multiple hypotheses testing, there were
no significant differences in macro- and micronutrient intakes between the NAFLD group and the
obese (Table 2). There continued to be no difference between groups after correcting for BMI z-score
(p > 0.001). Under-reporting was prevalent in both groups with 58% of participants with NAFLD
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and 85% of obese controls under-reporting dietary intakes, as assessed by 24-h recall. Additionally,
75% of participants with NAFLD and 87% of obese controls were deemed to have under-reported
their dietary intakes using the 7-day food diary. However, the number of under-reporters did not
significantly differ between groups when assessed using either the 24-h dietary recall (p = 0.37) or the
7-day food diary (p = 0.15).
Table 2. Nutritional intakes recorded via participant completed 7-day food diary or 24-h recall
expressed as % DRV or absolute intake.
Nutritional Intake as per 7-Day Food Diary Nutritional Intake as per 24-h Recall
Nutrient 1 NAFLD (n = 24) Control (n = 8) p-Value 2 NAFLD (n = 24) Control (n = 7) p-Value 2
Intakes of Nutrients Expressed as % DRV
Energy (%) 77.4 (67.0,101.2) 86.0 (74.4,114.1) 0.41 84.7 (56.3,101.7) 52.1 (43.6,93.6) 0.10
Protein (%) 153.6 (120.2,199.5) 169.2 (146.7,233.5) 0.26 148.6 (113.8,215.4) 104.9 (59.4,129.1) 0.02
Fat (%) 82.7 (50.1,105.6) 91.7 (67.1,118.4) 0.28 77.0 (47.3,105.0) 60.7 (39.8,66.5) 0.13
SFA (%) 97.4 (50.3,127.2) 108.3 (85.7,139.4) 0.36 93.6 (56.7,138.5) 61.5 (35.7,73.2) 0.05
MUFA (%) 79.5 (40.6,92.7) 89.7 (58.5,107.5) 0.30 61.9 (40.7,102.5) 53.0 (44.1,60.6) 0.34
PUFA (%) 67.0 (46.6,84.7) 82.0 (51.4,118.5) 0.34 44.0 (33.4,93.4) 57.9 (56.0,83.3) 0.17
Carbohydrate (%) 73.0 (56.0,95.2) 87.3 (65.4,95.3) 0.51 60.2 (44.8,85.2) 51.0 (39.3,83.4) 0.44
Sodium (%) 156.3 (110.9,201.4) 167.9 (106.2,199.3) 0.86 154.1 (91.2,232.0) 109.8 (86.1,131.1) 0.16
Potassium (%) 75.9 (50.5,90.8) 75.8 (63.2,97.7) 0.32 73.3 (51.9,97.23) 52.5 (45.3,78.7) 0.08
Calcium (%) 81.5 (51.1,114.6) 79.1 (72.5,106.3) 0.79 74.0 (32.9,110.8) 57.8 (43.7,77.6) 0.48
Iron (%) 61.4 (48.5,89.7) 72.5 (59.8,91.4) 0.40 63.0 (44.5,79.4) 43.4 (39.3,49.1) 0.05
Copper (%) 100.5 (78.2,148.2) 114.1 (99.7,114.1) 0.41 89.4 (62.5,153.9) 58.8 (52.0,75.0) 0.04
Zinc (%) 78.5 (61.0,118.3) 84.4 (78.4,112.9) 0.43 62.4 (51.4,103.7) 34.3 (33.3,56.6) 0.01
Vitamin E (%) 101.0 (63.7,147.5) 120.4 (86.0,186.2) 0.43 67.5 (40.6,116.1) 109.6 (84.2,155.4) 0.30
Vitamin B12 (%) 258.3 (167.7,330.5) 250.0 (139.3,545.4) 0.76 185.0 (115.3,489.2) 127.5 (55.3,190.0) 0.09
Folate (%) 88.0 (60.6,116.2) 91.6 (81.3,100.8) 0.60 67.7 (48.2,95.5) 50.6 (46.5,77.0) 0.32
Vitamin C (%) 187.1 (77.2,302.0) 211.2 (151.6,312.4) 0.43 181.0 (115.5,331.4) 82.5 (55.0,260.0) 0.19
Intakes of Nutrients Expressed as Absolute Intake
Starch (g) 119.4 (84.7,158.2) 127.4 (101.7,137.6) 0.83 105.4 (80.3,136.9) 107.2 (52.3,148.2) 0.67
Sugar (g) 87.5 (49.5,107.1) 93.0 (82.2,102.9) 0.49 63.5 (44.9,125.0) 49.9 (22.8,80.1) 0.24
NMES (g) 15.6 (5.1,25.0) 20.8 (11.4,28.7) 0.46 16.0 (2.0,36.6) 9.8 (0.0,21.4) 0.32
Fructose (g) 12.7 (8.9,18.4) 16.7 (10.9,19.4) 0.62 12.5 (6.3,20.2) 9.1 (2.1,19.4) 0.38
NSP (g) 10.7 (8.2,13.1) 10.1 (6.3,12.3) 0.41 8.7 (7.0,11.3) 4.1 (4.0,10.9) 0.14
Carotene (g) 1.9 (0.7,3.1) 3.0 (0.6,5.8) 0.32 1.0 (0.2,2.3) 0.4 (0.04,1.3) 0.22
Vitamin D (µg) 1.7 (1.3,2.2) 3.5 (1.0,4.4) 0.32 1.8 (1.2,3.6) 1.9 (0.3,2.9) 0.45
Omega-3 Fatty
Acids (g) 0.5 (0.3,0.9) 0.5 (0.15,1.4) 0.91 0.5 (0.2,0.8) 0.3 (0.2,0.4) 0.59
1 Data are expressed as median (1st quartile, 3rd quartile); 2 p-values from Mann-Whitney Test with
Bonferroni Correction; p < 0.001 is considered statistically significant. DRV: Dietary Reference Value; MUFA:
Monounsaturated Fatty Acids; NSP: non-starch polysaccharide, NMES: Non milk extrinsic sugars; PUFA:
Polyunsaturated Fatty Acids; SFA: Saturated Fatty Acids.
Although, there were no significant differences in the percent of energy derived from total
fat, SFA, MUFA or PUFA between groups, both the obese control and NAFLD group exceeded the
recommended percent of energy derived from saturated fat and received an insufficient proportion
of energy from PUFA and MUFA (Table 3). However, both groups met the recommendations for total
fat intake deriving less than 35% of energy from fat.
Table 3. Percentage of energy derived from total fat, SFA, MUFA and PUFA recorded via participant
completed 7-day food diary.
Nutrients Contributing
to Energy Intake 1
Recommended Daily Allowance
(Expressed as Percentage (%)
Total Energy Intake)
NAFLD (n = 24) Control (n = 8) p-Value 2
Total Fat <35 33.1 (28.2,38.6) 34.1 (32.6,36.6) 0.69
SFA <11 11.7 (9.6,13.7) 12.4 (11.4,13.2) 0.31
MUFA 13 10.4 (8.8,13.6) 11.9 (8.7,12.7) 0.68
PUFA 6.5 4.9 (4.2,6.2) 4.9 (4.2,6.8) 0.88
1 Data are expressed as median (1st quartile, 3rd quartile); 2 p-values from Mann-Whitney Test. p < 0.05 is
considered statistically significant.
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After controlling for differences in BMI z-score, responses to the Dutch Eating Behaviour
Questionnaire indicated that restrained eating behaviours were significantly higher in the NAFLD
group (p = 0.005) (Figure 2). In addition, NAFLD patients reported comparatively higher scores for
external (p = 0.112) and emotional eating behaviours (p = 0.068).
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Table 3. Percentage of energy derived from total fat, SFA, MUFA and PUFA recorded via participant 
completed 7‐day food diary. 
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Recommended 
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MUFA  13  10.4 (8.8,13.6)  11.9 (8.7,12.7)  0.68 
PUFA  6.5  4.9 (4.2,6.2)  4.9 (4.2,6.8)  0.88 
1 Data are expressed as median (1st quartile, 3rd quartile); 2 p‐values from Mann‐Whitney Test. p < 0.05 
is considered statistically significant. 
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spent a large proportion of their time in sedentary behaviour with minimal vigorous activity (Table 
4  and  Figure  3).  The  7‐day  activity  diary  suggested  that NAFLD  patients  spent more  time  on 
weekdays  in moderate  activity  (p  =  0.06) while  controls  had more weekday  time  (22%  vs.  5%) 
unaccounted  for  (Table 4).  Interestingly,  twenty‐five percent of participants  in  the NAFLD group 
reported meeting the UK physical activity requirements of 60 min of moderate to vigorous activity 
per day [31], using the physical activity levels recorded in the 7‐day activity diary. In contrast, none 
of the obese controls met these guidelines. However, there were no significant differences between 
groups  in the median amount of time per day (Table 4) or per week (Figure 3) spent undertaking 
sedentary, light, moderate or vigorous activity after controlling for BMI z‐score. 
Table 4. Physical Activity Levels expressed as amount of  time  (%) per day  recorded using 7‐day 
activity diary. 
Physical Activity Levels 1 (% per Day)  NAFLD (n = 22–24) Control (n = 8)  p‐Value 2
Sedentary 
(MET 1.0–1.5) 
7‐day Average  25 (16,32)  20 (13,28)  0.43 
Weekday Average  22 (16,30)  23 (16,31)  0.95 
Weekend Average  29 (6,36)  16 (10,22)  0.22 
Light (MET 1.6–
2.9) 
7‐day Average  18 (9,23)  13 (5,26)  0.73 
Weekday Average  25 (11,28)  16 (6,31)  0.41 
Figure 2. Eating styles in NAFLD and obese c ildren as assessed by Dutch Eating Behaviour
Questionnaires. Data adjusted for differences i I Z-score using ANCOVA and a expressed as
estimated arginal mean ˘ standard error of the ean (SEM). NAFLD (n = 23) Control (n = 8).
3.3. Physical Activity Levels
Physical activity levels, assessed usi g both the 7-day diary and PAQ, indicated that p rticipants
spent a l rge proportion of their time in sedentary behaviour with minimal vigorous activity
(Table 4 and Figure 3). The 7-day activity diary suggested that NAFLD patients spent more time
on weekdays in moderate activity (p = 0.06) while controls had more weekday time (22% vs. 5%)
unaccounted for (Table 4). Interestingly, twenty-five percent of participants in the NAFLD group
reported meeting the UK physical activity requirements of 60 min of moderate to vigorous activity
per day [31], using th physical activity levels record d in the 7-day activity diary. In contrast, none
of the obese controls et these guidelines. However, there were no significant differences between
groups in the median amount of time per day (Table 4) or per week (Figur 3) spent undertaking
sedentary, light, moderate or vigorous activity after controlling for BMI z-score.
Table 4. Physical Activity Levels expressed as amount of time (%) per day recorded using 7-day
activity diary.
Physical Activity Levels 1 (% per Day) NAFLD (n = 22–24) Control (n = 8) p-Value 2
Sedentary (MET 1.0–1.5)
7-day Average 25 (16,32) 20 (13,28) 0.43
Weekday Average 22 (16,30) 23 (16,31) 0.95
Weekend Average 29 (6,36) 16 (10,22) 0.22
Light (MET 1.6–2.9)
7-day Average 18 (9,23) 13 (5,26) 0.73
Weekday Average 25 (11,28) 16 (6,31) 0.41
Weekend Average 6 (1,14) 8 (3,13) 0.71
Moderate (MET 3.0–5.9)
7-day Average 5 (3,7) 3 (3,4) 0.31
Weekday Average 5 (3,7) 2 (1,4) 0.06
Weekend Average 4 (1,8) 7 (5,11) 0.13
Vigorous (MET > 6)
7-day Average 2 (0,3) 1 (0,2) 0.28
Weekday Average 2 (0,4) 1 (0,2) 0.19
Weekend Average 0 (0,3) 0 (0,1) 0.48
Sleep (MET 0.9)
7-day Average 40 (38,43) 42 (38,46) 0.33
Weekday Average 39 (36,42) 41 (37,41) 0.32
Weekend Average 44 (42,46) 45 (39,45) 0.62
Unaccounted
7-day Average 7 (7,22) 19 (5,32) 0.15
Weekday Average 5 (5,10) 22 (5,30) 0.08
Weekend Average 6 (0,21) 20 (9,28) 0.16
1 Data are expressed as median (1st quartile, 3rd quartile); 2 p-values from Mann-Whitney Test. p < 0.05 is
considered statistically significant. MET: Metabolic Equivalent of Task.
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is considered statistically significant. MET: Metabolic Equivalent of Task. 
 
Figure 3. Physical activity levels expressed as amount of time per week (%) calculated using the Youth 
or Children’s Physical Activity Questionnaire. Data are expressed as percent time per week. NAFLD 
(n = 16) Control (n = 8). 
In  addition  to  the  physical  activity  diary,  participants  recorded  step  counts  assessed  by  a 
pedometer. On average, the NAFLD group took more steps than the obese controls (p = 0.01) (Figure 
4). There was no  significant difference between  the number of  steps  taken on  a weekday  and  a 
weekend days in the NAFLD group (p = 0.062), whereas participants in the obese control group took 
more steps on weekday compared to a weekend (p = 0.046). 
 
Figure  4. Average  steps  recorded  using  pedometer during  participant  completed  7‐day  physical 
activity diary. Data are unadjusted and expressed as median + 3rd quartile. p‐values  from Mann‐
Whitney Test.  p  <  0.05  is  considered  statistically  significant. Dashed  line  represents  10,000  steps; 
minimum  number  of  steps  required  by  adolescence  to  meet  60  min/day  moderate‐to‐vigorous 
physical activity recommendation [32]. 
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Figure 3. Physical activity levels expressed as amount of time per week (%) calculated using the Youth
or Children’s Physical Activity Questionnaire. Data are expressed as percent time per week. NAFLD
(n = 16) Control (n = 8).
In addition to the physical activity diary, participants recorded step counts assessed by
a pedometer. On average, the NAFLD group took more steps than the obese controls (p = 0.01)
(Figure 4). There was no significant difference between the number of steps taken on a weekday and
a weekend days in the NAFLD group (p = 0.062), whereas participants in the obese control group
took more steps on weekday compared to a weekend (p = 0.046).
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4. Discussion
This is the first study to compare macro- and micronutrient intakes, eating behaviours and
physical activity behaviours of UK paediatric NAFLD patients to obese children without evidence
of liver disease. Anthropometric measurements were similar between groups with the exception of
BMI z-score and BMI centile, which were higher in the obese control group. Accumulation of visceral
fat has been implicated in the development and progression of NAFLD in both adults and children,
suggesting that distribution of adipose tissue may be more influential in determining NAFLD risk
than overall adiposity [33,34]. Despite no difference in waist circumference, further exploration and
comparison of body composition between groups may have provided insight into whether visceral
fat mass influenced NAFLD development in this cohort. A significant association between group
and self/guardian-reported ethnicity was identified. Ethnic variation in NAFLD prevalence has
previously been established, with studies in the USA noting higher prevalence of NAFLD amongst
Hispanics, followed by white European-Americans, with lowest disease prevalence observed in black
African-Americans [35]. This was subsequently associated with ethnic variation in the prevalence of
allelic variants of the patatin-like phospholipase 3 (PNPLA3) gene; with the PNPLA3 rs738409 (G)
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allele strongly associated with increased hepatic steatosis and inflammation [36]. Given that the
majority of participants with NAFLD were White British, compared to a majority of Black British
children in the control group, it would be interesting to explore whether a higher prevalence of
PNPLA3 rs738409 (G) exists in this NAFLD cohort.
After controlling for differences in BMI and correcting for multiple hypotheses testing, we found
no significant differences in macro- or micronutrient intake between groups. This includes nutrients
such as fructose, fatty acids and vitamin D previously implicated in NAFLD pathogenesis. The fact
that there were no statistical differences in fructose intake between groups opposes the results of
a number of previous studies noting increased fructose consumption in NAFLD patients [15,37–39].
However, our findings are consistent with a 2014 systematic review and meta-analysis where
reviewers concluded that any observed detrimental effects of excess dietary fructose might be
attributable to excessive energy intake rather than increased fructose consumption in isolation [40].
While there were no differences between the NAFLD and obese groups, reported intakes of MUFA
and PUFA were below UK recommendations; with low intakes of omega-3 fatty acids. Considering
that previous studies have linked MUFA with reduced hepatic steatosis [41] and improved insulin
sensitivity [41], and PUFA (in particular omega-3) with improvements in LFTs [42,43], serum
triglyceride (TG) and fasting blood glucose levels [42]; dietary deficiencies in MUFA and PUFA
are of concern. Education on accessible dietary sources of unsaturated fatty acids should remain
a priority in this population. Equally, although there were no statistical differences in vitamin D
consumption between groups, vitamin D intakes (1.7–3.5 µg/day) were well below the new proposed
UK recommended nutrient intake for vitamin D of 10 µg/day [44]. As vitamin D is derived both
exogenously, from dietary sources, and endogenously, by dermal synthesis following exposure to
UVB radiation [9], further research should be completed to assess the influence of both vitamin D
intake and serum 25 (OH)D levels on NAFLD pathogenesis in a paediatric UK cohort.
A key observation was the severe degree of under-reporting dietary intakes. Under-reporting is
known to be particularly common in obese subjects, characterised by reporting relatively low intakes
of foods which may be perceived as socially undesirable [45,46]. In addition, under-reporting may
have been unintentional, with reliance on memory and inexperience of portion size estimation known
to limit accurate dietary recall in children [47]. Despite a lack of significant difference in macro-
and micronutrient intake between groups, the majority of children in this cohort were consuming
well below the DRV for most nutrients. Although, rates of under-reporting were high and reported
intake may be lower than actual intake, there should be a focus on promoting intake of a wide
range of nutritious foods to assist children in consuming sufficient macro- and micronutrients to
meet UK recommendations. While certain eating behaviours are closely linked with obesity [48],
few studies have assessed eating behaviours amongst children with NAFLD. Interestingly, in this
cohort restrained eating behaviours were higher in the NAFLD group after controlling for BMI,
which suggests that children with NAFLD are more cautious of their dietary intake. Hattar et al. [16]
compared nutrition attitudes of obese children with NASH to obese control children and found 35%
of the NASH group consistently read nutritional information labels on food/beverages, compared to
0% of controls. Consequently, the greater awareness of dietary intake by children in the present study
may be a consequence of the NAFLD diagnosis.
Equally notable, children with NAFLD in this study were more physically active and took
more steps than their obese counterparts. Indeed, twenty-five percent of participants with NAFLD
met the UK physical activity guidelines [31], whereas all participants in the control group failed to
meet this recommendation. While the most appropriate duration and intensity of physical activity
for the treatment of NAFLD remains to be established, a number of adult studies have noted
metabolic benefits of regular, moderate-intensity activity in NAFLD patients, including decreases
in visceral adiposity and hepatic TG concentration [49]. As our study noted no clear differences in
activity levels between participants with NAFLD and obese controls, general paediatric guidelines
for physical activity should be encouraged in all overweight/obese children. Additionally, there
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should be a particular emphasis on encouraging physical activity outside of school hours, as we
noted a substantial decline in steps taken on weekends compared to weekdays.
A key strength of this study was the use of liver biopsy to diagnose NAFLD rather than reliance
on LFTs or ultrasound, considered to be low sensitivity diagnostic tools [5]. Although controls were
not precisely BMI-matched to NAFLD participants, both groups were of similar weight status. This is
of key importance in identifying risk factors other than obesity, which may contribute to NAFLD
development. An additional strength was the high levels of support received by participants in
completion of food and activity diaries, through home visits and telephone calls, maximising accuracy
of diary completion. On the other hand, a limitation of this study was the low number of controls
compared to NAFLD participants increasing the risk of a Type 2 error. It was much more difficult to
successfully recruit control subjects, reflecting a wider issue of low compliance in overweight/obese
children with weight reduction initiatives [50]. Additionally, due to the specialised nature of
the paediatric NAFLD clinic, referrals were received from across south-west England whereas the
patients for the multidisciplinary obesity clinic has a significant proportion of individuals from
a region in London with a large population of individuals from African and Caribbean descent [51],
skewing the ethnic distribution between groups. Lastly, some of the subjects might have previously
seen a dietitian, or received dietary advice upon diagnosis, leading to altered eating and physical
activity behaviors during completion of the study protocol. However, all patients were assessed
according to the growth trajectory on Royal College of Paediatrics and Child Health growth charts
to ensure no loss of growth centiles, indicating weight loss, had been seen in the previous months
during diagnosis.
5. Conclusions
In summary, no differences in macro- or micronutrient intakes were observed between children
with NAFLD and obese controls in this study. Under-reporting in both groups was prevalent.
Restrained eating behaviours were significantly higher in the NAFLD group, who were also more
physically active and took more steps than their obese counterparts. Further research is required
to confirm the role of particular nutrients in the development and progression of NAFLD and to
establish optimal physical activity guidelines for children with NAFLD. Only a minority of cases and
controls were meeting current dietary and physical activity recommendations and general healthy
eating advice, alongside a minimum of 60 min moderate-vigorous physical activity per day should
continue to be encouraged [31]. Additionally, the fact that children in the control group were of
significantly higher BMI than children in the NAFLD group suggests excess body weight is not the
only driving factor in NAFLD development. Genetic susceptibility, ethnicity, the gut microbiome and
visceral fat accumulation may all play a role in the risk of developing NAFLD.
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